|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Depreciation | |||||
| Bond discount amortization | |||||
| Provision for current estimate of credit losses | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Non-cash operating lease credit | |||||
| Non-cash operating lease expense (credit) | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Accounts payable | |||||
| Accrued payroll and other | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Purchases of marketable securities | |||||
| Proceeds from maturities of marketable securities | |||||
| Receipt of tenant improvement allowance | |||||
| Purchases of fixed assets | |||||
| Net cash (used in) provided by investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Payment of dividends to shareholders | |||||
| Net proceeds from exercise of stock options | |||||
| Repurchase of common stock | |||||
| Net cash used in financing activities | |||||
| Decrease in cash and cash equivalents | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Beginning Balance | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Ending Balance | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid during the year for income taxes | |||||
Loading...